Brain-reactive autoantibodies prevalent in human sera increase intraneuronal amyloid-β1-42 deposition

Journal of Alzheimer's Disease

Volumn 25, Issue 4, 2011, Pages 605-622

  Nagele, Robert G ^a   Clifford, Peter M ^a   Siu, Gilbert ^a   Levin, Eli C ^a   Acharya, Nimish K ^a   Han, Min ^a   Kosciuk, Mary C ^a   Venkataraman, Venkat ^b   Zavareh, Semah ^a   Zarrabi, Shabnam ^a   Kinsler, Kristin ^a   Thaker, Nikhil G ^a   Nagele, Eric P ^c   Dash, Jacqueline ^a   Wang, Hoau Y ^d   Levitas, Andrew ^b  

^a UMDNJ School of Osteopathic Medicine   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c Durin Technologies Inc   (United States)

^d CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer's disease; amyloid; autoantibodies; autoimmunity; blood brain barrier; neurodegenerative disease

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AUTOANTIBODY; BRAIN REACTIVE AUTOANTIBODY; IMMUNOGLOBULIN G; MEMBRANE PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN REGION; BRAIN SLICE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; MOUSE; NERVE CELL; NONHUMAN; PATHOLOGY; PERIKARYON; PRIORITY JOURNAL; PROTEIN FUNCTION; SERUM;

EID: 79961077855     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110098     Document Type: Article

References (91)

1. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791. (Pubitemid 35231524)
2. Hamos JE, DeGennaro LJ, Drachman DA (1989) Synaptic loss in Alzheimer's disease and other dementias. Neurology 39, 355-361. (Pubitemid 19094725)
3. Masliah E (1995) Mechanisms of synaptic dysfunction in Alzheimer's disease. Histol Histopathol 10, 509-519.
4. Bertoni-Freddari C, Fattoretti P, Solazzi M, Giorgetti B, Di Stefano G, Casoli T, Meier-Ruge W (2003) Neuronal death versus synaptic pathology in Alzheimer's disease. Ann N Y Acad Sci 1010, 635-638. (Pubitemid 38265057)
5. Scheff SW, Price DA, Schmitt FA, Mufson EJ (2006) Hip-pocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 27, 1372-1384. (Pubitemid 44279897)
6. D'Andrea MR, Nagele RG, Wang HY, Peterson PA, Lee DH (2001) Evidence that neurones accumulating amyloid can undergo lysisto form amyloid plaquesinAlzheimer's disease. Histopathology 38, 120-134. (Pubitemid 32193626)
7. Dickson DW (1997) The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56, 321-339. (Pubitemid 27465015)
8. Nagele RG, D'Andrea MR, Anderson WJ, Wang HY (2002) Intracellular accumulation of beta-amyloid (1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 110, 199-211. (Pubitemid 34214939)
9. Nagele RG, D'Andrea MR, Lee H, Venkataraman V, Wang HY (2003) Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaquesin Alzheimer disease brains. Brain Res 971, 197-209. (Pubitemid 36423321)
10. Schwab C, McGeer PL (2008) Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J Alzheimers Dis 13, 359-369. (Pubitemid 352039027)
11. Thal DR, Griffin WS, de Vos RA, Ghebremedhin E (2008) Cerebral amyloid angiopathy and its relationship to Alzheimer's disease. Acta Neuropathol 115, 599-609.
12. Weisman D, Hakimian E, Ho GJ (2006) Interleukins, inflammation, and mechanisms of Alzheimer's disease. Vitam Horm 74, 505-530.
13. Wisniewski KE, Wisniewski HM, Wen GY (1985) Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 17, 278-282. (Pubitemid 15136603)
14. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield JP, Haroutunian V, Buxbaum JD, Xu H, Greengard P, Relkin NR (2000) Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156, 15-20. (Pubitemid 30644433)
15. Clifford PM, Siu G, Kosciuk M, Levin EC, Venkataraman V, D'Andrea MR, Nagele RG (2008) Alpha7 nicotinic acetyl-choline receptor expression by vascular smooth muscle cells facilitates the depositionofAbeta peptides and promotes cere-brovascular amyloid angiopathy. Brain Res 1234, 158-171.
16. Wang HY, D'Andrea MR, Nagele RG (2002) Cerebellar diffuse amyloid plaques are derived from dendritic Abeta42 accumulations in Purkinje cells. Neurobiol Aging 23, 213-223. (Pubitemid 34137095)
17. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM (2003) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 24, 1063-1070. (Pubitemid 37487883)
18. Shie FS, LeBoeuf RC, Jin LW (2003) Early intraneuronal Abeta deposition inthe hippocampusof APP transgenic mice. Neuroreport 14, 123-129.
19. Lanz TA, Carter DB, Merchant KM (2003) Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol Dis 13, 246-253. (Pubitemid 36937206)
20. Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yam-aguchi H, Beal MF, Xu H, Greengard P, Gouras GK (2002) Intraneuronal Alzheimer abeta42 accumulates in multivesic-ular bodies and is associated with synaptic pathology. Am J Pathol 161, 1869-1879. (Pubitemid 35265544)
21. Alpar A, Ueberham U, Bruckner MK, Seeger G, Arendt T, Gartner U (2006) Different dendrite and dendritic spine alterations in basal and apical arbors in mutant human amyloid precursor protein transgenic mice. Brain Res 1099, 189-198. (Pubitemid 44080101)
22. Deane R, Zlokovic BV (2007) Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. Curr Alzheimer Res 4, 191-197. (Pubitemid 46562394)
23. Hawkins BT, Davis TP (2005) The blood-brain bar-rier/neurovascular unit in health and disease. Pharmacol Rev 57, 173-185. (Pubitemid 41043883)
24. Kalaria RN (1999) The blood-brain barrier and cerebrovascu-lar pathology in Alzheimer's disease. Ann N Y Acad Sci 893, 113-125. (Pubitemid 30038071)
25. Kalaria RN (2003) Vascular factors in Alzheimer's disease. Int Psychogeriatr 15 Suppl 1, 47-52. (Pubitemid 37175166)
26. de la Torre JC, Mussivand T (1993) Can disturbed brain microcirculation cause Alzheimer's disease? Neurol Res 15, 146-153. (Pubitemid 23166998)
27. Bouras C, Riederer BM, Kovari E, Hof PR, Giannakopoulos P (2005) Humoral immunity in brain aging and Alzheimer's disease. Brain Res Brain Res Rev 48, 477-487. (Pubitemid 40731511)
28. D'Andrea MR (2003) Evidence linking neuronal cell death to autoimmunity in Alzheimer's disease. Brain Res 982, 19-30. (Pubitemid 37288794)
29. Stein TD, Fedynyshyn JP, Kalil RE (2002) Circulating autoan-tibodies recognize and bind dying neurons following injury to the brain. J Neuropathol Exp Neurol 61, 1100-1108. (Pubitemid 35435029)
30. Levin EC, Acharya NK, Han M, Zavareh SB, Sedeyn JC, Venkataraman V, Nagele RG Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood-brain barrier breakdown. Brain Res 1345, 221-232.
31. Nandy K, Fritz RB, Threatt J (1975) Specificity of brain-reactive antibodies in serum of old mice. J Gerontol 30, 269-274.
32. Franceschi M, Comola M, Nemni R, Pinto P, Iannaccone S, Smirne S, Canal N (1989) Neuron-binding antibodies in Alzheimer's disease and Down's syndrome. J Gerontol 44, M128-M130. (Pubitemid 19186293)
33. Kulmala HK, Boja JW, Albrecht JW, Hutton JT (1987) Brain reactive antibodies and the blood-brain barrier: observations in aging rodents and the effects of peripheral kainic acid. Exp Aging Res 13, 67-72. (Pubitemid 17125019)
34. Alafuzoff I, Adolfsson R, Bucht G, Winblad B (1983) Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia. J Neurol Sci 60, 465-472. (Pubitemid 13051197)
35. Clifford PM, Zarrabi S, Siu G, Kinsler KJ, Kosciuk MC, Venkataraman V, D'Andrea MR, Dinsmore S, Nagele RG (2007) Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons. Brain Res 1142, 223-236. (Pubitemid 46413194)
36. Hyman BT, Trojanowski JQ (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56, 1095-1097.
37. Stoppini L, Buchs PA, Muller D (1991) A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37, 173-182.
38. Malouf AT (1992) Effect of beta amyloid peptides on neurons in hippocampal slice cultures. Neurobiol Aging 13, 543-551.
39. Tienari PJ, Ida N, Ikonen E, Simons M, Weidemann A, Multhaup G, Masters CL, Dotti CG, Beyreuther K (1997) Intracellular and secreted Alzheimer beta-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons. Proc Natl Acad Sci USA 94, 4125-4130. (Pubitemid 27180510)
40. Loeffler DA, Juneau PL, Nguyen HU, Najman D, Pomara N, LeWitt PA (1997) Immunocytochemical detection of anti-hippocampal antibodies in Alzheimer's disease and normal cerebrospinal fluid. Neurochem Res 22, 209-214. (Pubitemid 27069098)
41. Mooradian AD (1988) Effect of aging on the blood-brain barrier. Neurobiol Aging 9, 31-39. (Pubitemid 18063330)
42. Harris-White ME, Chu T, Balverde Z, Sigel JJ, Flanders KC, Frautschy SA (1998) Effects of transforming growth factor-beta (isoforms 1-3) on amyloid-beta deposition, inflammation, and cell targeting in organotypic hippocampal slice cultures. J Neurosci 18, 10366-10374. (Pubitemid 29016556)
43. Bahr BA, Hoffman KB, Yang AJ, Hess US, Glabe CG, Lynch G (1998) Amyloid beta protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragmentsofthe amyloid precursor protein. J Comp Neurol 397, 139-147. (Pubitemid 28304057)
44. Mecocci P, Ekman R, Parnetti L, Senin U (1993) Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. Biol Psychiatry 34, 380-385. (Pubitemid 23295754)
45. Mecocci P, Parnetti L, Romano G, Scarelli A, Chionne F, Cecchetti R, Polidori MC, Palumbo B, Cherubini A, Senin U (1995) Serum anti-GFAP and anti-S100 autoantibodies in brain aging, Alzheimer's disease and vascular dementia. J Neuroimmunol 57, 165-170.
46. Weksler ME, Goodhardt M (2002) Do age-associated changes in 'physiologic' autoantibodies contribute to infection, atherosclerosis, and Alzheimer's disease? Exp Gerontol 37, 971-979.
47. Diamond B, Huerta PT, Mina-Osorio P, Kowal C, Volpe BT (2009) Losing your nerves? Maybe it's the antibodies. Nat Rev Immunol 9, 449-456.
48. Chengappa KN, Carpenter AB, Keshavan MS, Yang ZW, Kelly RH, Rabin BS, Ganguli R (1991) Elevated IGG and IGM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients. Biol Psychiatry 30, 731-735.
49. Firer M, Sirota P, Schild K, Elizur A, Slor H (1994) Anticardi-olipin antibodies are elevated in drug-free, multiply affected families with schizophrenia. J Clin Immunol 14, 73-78. (Pubitemid 24071702)
50. Ganguli R, Rabin BS, Brar JS (1992) Antinuclear and gastric parietal cell autoantibodies in schizophrenic patients. Biol Psychiatry 32, 735-738.
51. Sirota P, Firer MA, Schild K, Tanay A, Elizur A, Meytes D, Slor H (1993) Autoantibodies to DNA in multicase families with schizophrenia. Biol Psychiatry 33, 450-455. (Pubitemid 23149166)
52. Monestier M, Kotzin BL (1992) Antibodies to histones in systemic lupus erythematosus and drug-induced lupus syndromes. Rheum Dis Clin North Am 18, 415-436.
53. Dabelic N, Cikes N (1997) [Clinical importanceofantinuclear antibodies]. Lijec Vjesn 119, 236-242.
54. Irani S, Lang B (2008) Autoantibody-mediated disorders of the central nervous system. Autoimmunity 41, 55-65.
55. Graus F, Saiz A, Dalmau J (2009) Antibodies and neu-ronal autoimmune disorders of the CNS. J Neurol. 257, 509-517.
56. Gordon N (2009) Sydenham's chorea, and its complications affecting the nervous system. Brain Dev 31, 11-14.
57. Hoekstra PJ, Minderaa RB (2005) Tic disorders and obsessive-compulsive disorder:isautoimmunity involved?Int Rev Psychiatry 17, 497-502. (Pubitemid 43086676)
58. Mocellin R, Walterfang M, Velakoulis D (2007) Hashimoto's encephalopathy: epidemiology, pathogenesis and management. CNS Drugs 21, 799-811. (Pubitemid 47443302)
59. Kirvan CA, Swedo SE, Snider LA, Cunningham MW (2006) Antibody-mediated neuronal cell signaling in behavior and movement disorders. J Neuroimmunol 179, 173-179. (Pubitemid 44472532)
60. Kowal C, DeGiorgio LA, Nakaoka T, Hetherington H, Huerta PT, Diamond B, Volpe BT (2004) Cognition and immunity; antibody impairs memory. Immunity 21, 179-188. (Pubitemid 39094048)
61. Diamond B, Kowal C, Huerta PT, Aranow C, Mackay M, DeGiorgio LA, Lee J, Triantafyllopoulou A, Cohen-Solal J, Volpe BT (2006) Immunity and acquired alterations in cognition and emotion: lessons from SLE. Adv Immunol 89, 289-320.
62. Bluestein HG, Zvaifler NJ (1983) Antibodies reactive with central nervous system antigens. Hum Pathol 14, 424-428. (Pubitemid 13093253)
63. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A (2001) The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 57, 496-500. (Pubitemid 32757599)
64. Loukkola J, Laine M, Ainiala H, Peltola J, Metsanoja R, Auvi-nenA, Hietaharju A (2003) Cognitive impairment in systemic lupus erythematosus and neuropsychiatricsystemic lupus ery-thematosus: a population-based neuropsychological study. J Clin Exp Neuropsychol 25, 145-151. (Pubitemid 36461164)
65. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B (2001) A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 7, 1189-1193. (Pubitemid 33063773)
66. Farkas E, Luiten PG (2001) Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 64, 575-611. (Pubitemid 32304447)
67. Bailey TL, Rivara CB, Rocher AB, Hof PR (2004) The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease. Neurol Res 26, 573-578. (Pubitemid 38879242)
68. Terryberry JW, Thor G, Peter JB (1998) Autoantibodies in neurodegenerative diseases: antigen-specific frequencies and intrathecal analysis. Neurobiol Aging 19, 205-216. (Pubitemid 28331297)
69. Chapman J, Bachar O, Korczyn AD, Wertman E, Michaelson DM (1989) Alzheimer's disease antibodies bind specifically to a neurofilament protein in Torpedo cholinergic neurons. J Neurosci 9, 2710-2717. (Pubitemid 19214307)
70. Mor F, Izak M, Cohen IR (2005) Identification of aldolase as a target antigen in Alzheimer's disease. J Immunol 175, 3439-3445. (Pubitemid 41170568)
71. Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer's disease. Lancet 368, 387-403. (Pubitemid 44108123)
72. LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 8, 499-509.
73. Nagele RG, Wegiel J, Venkataraman V, Imaki H, Wang KC (2004) Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol Aging 25, 663-674. (Pubitemid 38686490)
74. Fuentealba RA, Liu Q, Zhang J, Kanekiyo T, Hu X, Lee JM, LaDu MJ, Bu G (2010) Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake and lysosomal trafficking. PLoS One 5, e11884.
75. Wang HY, Lee DH, D'Andrea MR, Peterson PA, Shank RP, Reitz AB (2000) beta-Amyloid (1-42) binds to alpha7 nico-tinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J Biol Chem 275, 5626-5632. (Pubitemid 30115201)
76. Wang HY, Lee DH, Davis CB, Shank RP (2000) Amyloidpep-tide Abeta (1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J Neurochem 75, 1155-1161. (Pubitemid 30660505)
77. Wang HY, Bakshi K, Shen C, Frankfurt M, Trocme-Thibierge C, Morain P (2009) S 24795 Limits beta-Amyloid-alpha7 Nicotinic Receptor Interaction and Reduces Alzheimer's Disease-Like Pathologies. Biol Psychiatry. 67, 522-530.
78. Wang HY, Stucky A, Liu J, Shen C, Trocme-Thibierge C, Morain P (2009) Dissociating beta-amyloid from alpha 7 nicotinic acetylcholine receptor by a novel therapeutic agent, S 24795, normalizes alpha 7 nicotinic acetylcholine and NMDA receptor functionin Alzheimer's disease brain.J Neu-rosci 29, 10961-10973.
79. Dziewczapolski G, Glogowski CM, Masliah E, Heinemann SF (2009) Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease. J Neurosci 29, 8805-8815.
80. Salisbury JL, Condeelis JS, Satir P (1980) Role of coated vesicles, microfilaments, and calmodulin in receptor-mediated endocytosis by cultured B lymphoblastoid cells. J Cell Biol 87, 132-141.
81. Wehland J, Willingham MC, Gallo MG, Rutherford AV, Rudick J, Dickson RB, Pastan I (1982) Microinjection of anti-clathrin antibodies into cultured fibroblasts: clathrin-coated structuresinreceptor-mediated endocytosis and in exocytosis. Cold Spring Harb Symp Quant Biol 46 Pt 2, 743-753.
82. Abulrob A, Sprong H, Van Bergen en Henegouwen P, Sta-nimirovic D (2005) The blood-brain barrier transmigrating single domain antibody: mechanisms of transport and anti-genic epitopes in human brain endothelial cells. J Neurochem 95, 1201-1214. (Pubitemid 41713502)
83. Rosenthal AS, Davie JM, Rosenstreich DL, Cehrs KU (1973) Antibody-mediated internalization of B lymphocyte surface membrane immunoglobulin. Exp Cell Res 81, 317-329.
84. Schwartz AL, Ciechanover A, Merritt S, Turkewitz A (1986) Antibody-induced receptor loss. Different fates for asialo-glycoproteins and the asialoglycoprotein receptor in HepG2 cells. J Biol Chem 261, 15225-15232.
85. Mellman IS (1982) Endocytosis, membrane recycling and Fc receptor function. Ciba Found Symp 92, 35-58.
86. Cataldo AM, Nixon RA (1990) Enzymatically active lyso-somal proteases are associated with amyloid deposits in Alzheimer brain. Proc Natl Acad Sci USA 87, 3861-3865.
87. Cataldo AM, Barnett JL, Pieroni C, Nixon RA (1997) Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence foramechanism of increased beta-amyloidogenesis. J Neurosci 17, 6142-6151. (Pubitemid 27329890)
88. Grbovic OM, Mathews PM, Jiang Y, Schmidt SD, Dinakar R, Summers-Terio NB, Ceresa BP, Nixon RA, Cataldo AM (2003) Rab5-stimulated up-regulation of the endocytic pathway increases intracellular beta-cleaved amyloid precursor protein carboxyl-terminal fragment levels and Abeta production. J Biol Chem 278, 31261-31268. (Pubitemid 36994643)
89. Lennon VA, Ermilov LG, Szurszewski JH, Vernino S (2003) Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J Clin Invest 111, 907-913. (Pubitemid 37074966)
90. McKeon A, Lennon VA, Lachance DH, Fealey RD, Pittock SJ (2009) Ganglionic acetylcholinereceptor autoantibody:onco-logical, neurological, and serological accompaniments. Arch Neurol 66, 735-741.
91. Vernino S, Hopkins S, Wang Z (2009) Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune gan-glionopathy. Auton Neurosci 146, 3-7.